Evofem Biosciences Inc (EVFM)
0.0132
0.00 (0.00%)
USD |
OTCM |
Nov 05, 11:00
Evofem Biosciences Total Liabilities (Quarterly): 73.18M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 73.18M |
| March 31, 2024 | 74.24M |
| December 31, 2023 | 77.06M |
| September 30, 2023 | 67.88M |
| June 30, 2023 | 69.74M |
| March 31, 2023 | 82.44M |
| December 31, 2022 | 96.96M |
| September 30, 2022 | 120.33M |
| June 30, 2022 | 269.47M |
| March 31, 2022 | 162.67M |
| December 31, 2021 | 142.09M |
| September 30, 2021 | 126.25M |
| June 30, 2021 | 99.78M |
| March 31, 2021 | 107.10M |
| December 31, 2020 | 108.62M |
| September 30, 2020 | 72.12M |
| June 30, 2020 | 66.52M |
| March 31, 2020 | 14.62M |
| December 31, 2019 | 12.66M |
| September 30, 2019 | 14.91M |
| June 30, 2019 | 18.62M |
| Date | Value |
|---|---|
| March 31, 2019 | 32.08M |
| December 31, 2018 | 27.37M |
| September 30, 2018 | 25.09M |
| June 30, 2018 | 20.91M |
| March 31, 2018 | 27.28M |
| December 31, 2017 | 103.63M |
| September 30, 2017 | 1.396M |
| June 30, 2017 | 1.701M |
| March 31, 2017 | 1.698M |
| December 31, 2016 | 0.9022M |
| September 30, 2016 | 1.432M |
| June 30, 2016 | 6.542M |
| March 31, 2016 | 7.029M |
| December 31, 2015 | 16.30M |
| September 30, 2015 | 19.94M |
| June 30, 2015 | 14.61M |
| March 31, 2015 | 13.28M |
| December 31, 2014 | 11.65M |
| September 30, 2014 | 5.661M |
| December 31, 2013 | 10.55M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
12.66M
Minimum
Dec 2019
269.47M
Maximum
Jun 2022
97.04M
Average
82.44M
Median
Mar 2023
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
| Oragenics Inc | 1.383M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.551M |
| Shareholders Equity (Quarterly) | -64.63M |
| Debt to Equity Ratio | -0.6697 |
| Current Ratio | 0.0986 |
| Net Debt Paydown Yield | 169.2% |